AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2002 JAN 10 - (NewsRx.com & NewsRx.net) -- ChromaVision Medical Systems,
Inc., manufacturer of the ACIS digital microscope system, announced that results of a study using the ACIS system statistically concluded that the number of metastatic tumor cells found in the sentinel lymph node correlates with the size of the primary breast tumor.
The data showed that sentinel nodes from patients with small primary tumors have fewer tumor cells and would require more extensive sectioning to detect metastases. When cancer is diagnosed at an early stage, tumor analysis may be performed at a time when the tumor size is still relatively small. The ACIS automated platform makes it practical to examine a greater number of lymph node sections than by manual evaluation improving the feasibility of this type of testing and increasing the likelihood of detecting metastases if they are present.
The ACIS system is designed to assist the pathologist by detecting, counting and classifying cells of clinical interest based on recognition of color, size, and shape. The findings were presented on December 10, 2001, at the 24th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas.
Sentinel lymph node analysis, in which the first one to three lymph nodes to receive drainage from the breast are tested for the presence of metastatic cancer cells, is becoming increasingly popular. This analysis is an alternative to the traditional method of removing 20 to 30 ...
Source: HighBeam Research, ChromaVision Technology Optimizes Lymph Node Analysis.(ChromaVision...